» Articles » PMID: 9155017

Mitogen-activated Protein Kinases Activate the Serine/threonine Kinases Mnk1 and Mnk2

Overview
Journal EMBO J
Date 1997 Apr 15
PMID 9155017
Citations 343
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein (MAP) kinases bind tightly to many of their physiologically relevant substrates. We have identified a new subfamily of murine serine/threonine kinases, whose members, MAP kinase-interacting kinase 1 (Mnk1) and Mnk2, bind tightly to the growth factor-regulated MAP kinases, Erk1 and Erk2. MNK1, but not Mnk2, also binds strongly to the stress-activated kinase, p38. MNK1 complexes more strongly with inactive than active Erk, implying that Mnk and Erk may dissociate after mitogen stimulation. Erk and p38 phosphorylate MNK1 and Mnk2, which stimulates their in vitro kinase activity toward a substrate, eukaryotic initiation factor-4E (eIF-4E). Initiation factor eIF-4E is a regulatory phosphoprotein whose phosphorylation is increased by insulin in an Erk-dependent manner. In vitro, MNK1 rapidly phosphorylates eIF-4E at the physiologically relevant site, Ser209. In cells, Mnk1 is post-translationally modified and enzymatically activated in response to treatment with either peptide growth factors, phorbol esters, anisomycin or UV. Mitogen- and stress-mediated MNK1 activation is blocked by inhibitors of MAP kinase kinase 1 (Mkk1) and p38, demonstrating that Mnk1 is downstream of multiple MAP kinases. MNK1 may define a convergence point between the growth factor-activated and one of the stress-activated protein kinase cascades and is a candidate to phosphorylate eIF-4E in cells.

Citing Articles

Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function.

Sharp S, Martella M, DAgostino S, Milton C, Ward G, Woodhead A Nat Commun. 2025; 15(1):10037.

PMID: 40016190 PMC: 11868579. DOI: 10.1038/s41467-024-54356-1.


RNA-binding proteins as therapeutic targets in cancer.

Jungfleisch J, Gebauer F RNA Biol. 2025; 22(1):1-8.

PMID: 40016176 PMC: 11869776. DOI: 10.1080/15476286.2025.2470511.


eIF4F-mediated dysregulation of mRNA translation in cancer.

Amiri M, Mahmood N, Tahmasebi S, Sonenberg N RNA. 2025; 31(3):416-428.

PMID: 39809544 PMC: 11874970. DOI: 10.1261/rna.080340.124.


Targeting protein synthesis pathways in MYC-amplified medulloblastoma.

Kumar D, Kanchan R, Chaturvedi N Discov Oncol. 2025; 16(1):23.

PMID: 39779613 PMC: 11711608. DOI: 10.1007/s12672-025-01761-7.


Perturbations in eIF3 subunit stoichiometry alter expression of ribosomal proteins and key components of the MAPK signaling pathways.

Herrmannova A, Jelinek J, Pospisilova K, Kerenyi F, Vomastek T, Watt K Elife. 2024; 13.

PMID: 39495207 PMC: 11534336. DOI: 10.7554/eLife.95846.


References
1.
Rao V, Reddy E . elk-1 proteins interact with MAP kinases. Oncogene. 1994; 9(7):1855-60. View

2.
Ginty D, Bonni A, Greenberg M . Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 1994; 77(5):713-25. DOI: 10.1016/0092-8674(94)90055-8. View

3.
Han J, Lee J, Bibbs L, Ulevitch R . A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994; 265(5173):808-11. DOI: 10.1126/science.7914033. View

4.
Minich W, Balasta M, Goss D, Rhoads R . Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form. Proc Natl Acad Sci U S A. 1994; 91(16):7668-72. PMC: 44463. DOI: 10.1073/pnas.91.16.7668. View

5.
Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D . A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994; 78(6):1027-37. DOI: 10.1016/0092-8674(94)90277-1. View